Boston Scientific has been granted a new technology add-on payment (NTPA) for its Eluvia drug-eluting vascular stent system from the Centers for Medicare & Medicaid Services. Under the Inpatient Prospective Payment System (IPPS), CMS pays for a patient’s inpatient hospital stay under one bundled payment, which covers all costs for